According to medical device experts, malignant glioma is a type of malignant tumor that originates in neuroepithelial tissue. On a global scale, its incidence rate is 3-10/101 million, which is the death of young and middle-aged people. The 3rd disease was the second highest among children. Malignant gliomas lag behind malignant tumors of other tissues and organs in the improvement of treatment methods. There has been no breakthrough in the past 30 years, and the survival period of patients has not been significantly improved. The curative effect is still maintained after surgery alone. The average survival time was 8 months, postoperative adjuvant radiotherapy and chemotherapy was only 11 months, and the median survival time was no more than 2 years. In this severe tumor situation, exploring new methods for treating malignant gliomas has always been the direction of medical workers.
According to the Oriental Medical Device Network, clinical trials of magnetic fluid magnetic induction therapy for brain glioma developed by Humboldt University in Germany and Magforce Corporation were completed in 2009 and have now been approved by the EU pharmaceutical regulatory agency. clinical. This is an exciting, gratifying message that has brought good news to the majority of glioma patients.
According to medical device experts, magnetic induction therapy is a new type of cancer treatment that has been rapidly developed after surgery, radiotherapy, and chemotherapy. This technology utilizes the physical properties of ferromagnetic materials that can heat up in an alternating magnetic field, and introduces ferromagnetic material as a heat medium into the tumor tissue. Under the action of an alternating magnetic field, the heat generated by the magnetic medium makes the temperature of the tumor tissue excessively high. Thermal effects kill tumor cells. The ferromagnetic heat medium can be classified into nano-sized magnetic fluids, micron-sized carbonyl iron powders, and millimeter-sized hot seeds according to its size.
According to the Oriental Medical Device Network, clinical trials of magnetic fluid magnetic induction therapy for brain glioma developed by Humboldt University in Germany and Magforce Corporation were completed in 2009 and have now been approved by the EU pharmaceutical regulatory agency. clinical. This is an exciting, gratifying message that has brought good news to the majority of glioma patients.
According to medical device experts, magnetic induction therapy is a new type of cancer treatment that has been rapidly developed after surgery, radiotherapy, and chemotherapy. This technology utilizes the physical properties of ferromagnetic materials that can heat up in an alternating magnetic field, and introduces ferromagnetic material as a heat medium into the tumor tissue. Under the action of an alternating magnetic field, the heat generated by the magnetic medium makes the temperature of the tumor tissue excessively high. Thermal effects kill tumor cells. The ferromagnetic heat medium can be classified into nano-sized magnetic fluids, micron-sized carbonyl iron powders, and millimeter-sized hot seeds according to its size.
Manual lifting chair with commode seat Transfer Chair to bed transport machine for patients waterproof,Patient Transfer Lift Chair with Commode Shower Wheelchair,
Transfer Chair
Transfer Chair,Transfer Chair with Commode,Patient Transfer Lift Chair with Commode Shower Wheelchair
jinan Fangqi Sunshine education consulting CO.,LTD. , https://www.fzrehabmarket.com